Management of extremity soft-tissue sarcomas requires accurate clinica
l staging, pathologic diagnosis, surgical resection with a wide margin
, and adjuvant radiation therapy for high-grade lesions. Brachytherapy
offers a clean benefit in local control for large (> 5 cm) high-grade
sarcomas. The role of radiation therapy for small high-grade and all
low-grade soft-tissue sarcomas still is being evaluated. Survival is f
unction of histologic grade, age of patient, size and location of the
tumor, metastases, and adequacy of the surgical resection. Efficacy of
chemotherapy has yet to be proven.